Profile of brivaracetam and its potential in the treatment of epilepsy

Brivaracetam (BRV) (UCB 34714) is currently under review by the US Food and Drug Administration and European Medicines Agency for approval as an add-on treatment for adult patients with partial seizures. Similar to levetiracetam (LEV), BRV acts as a high-affinity ligand of the synaptic vesicle prote...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropsychiatr Dis Treat
Hauptverfasser: Ferlazzo, Edoardo, Russo, Emilio, Mumoli, Laura, Sueri, Chiara, Gasparini, Sara, Palleria, Caterina, Labate, Angelo, Gambardella, Antonio, De Sarro, Giovambattista, Aguglia, Umberto
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2015
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4670022/
https://ncbi.nlm.nih.gov/pubmed/26664121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S60849
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge